Real-time enrollment status for this primary immunodeficiency clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT07076446 |
| Recruiting Status | Recruiting |
| Condition | Primary Immunodeficiency |
| Phase | Clinical Trial |
| Target Enrollment | 8 participants |
| Active Locations | 5 sites in the US |
| Sponsor | CSL Behring |
| Last Updated on CT.gov | December 11, 2025 (Dec 11, 2025) |
As of March 2, 2026: Clinical trial NCT07076446 is currently recruiting participants. This clinical trial study for primary immunodeficiency is actively seeking new participants at 5 locations across the United States. The study is sponsored by CSL Behring. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07076446 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07076446 was last updated Dec 11, 2025 (December 11, 2025). HelloStudys verifies this status automatically.